UNSPSC 51242205: Chloroxylenol/domiphen/hydrocortisone/pramoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT900. This VA Drug Class (OT900) classifies this compound as belonging to the group OTIC AGENTS, OTHER.

UNSPSC 51242205 Chloroxylenol/domiphen/hydrocortisone/pramoxine is a Commodity code that encompasses pharmaceutical preparations combining topical anesthetic, anti-inflammatory, and antimicrobial agents — products state and local government health systems and facilities procure as OTC treatments or pharmaceutical stock items. The recent solicitation activity shows state and local procurement bodies buying this product as part of broader generic multi-source pharmaceutical and OTC product contracts, not as a standalone item. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body active under this code, acting on behalf of participating state and local government facilities across multiple states including Oregon.

MMCAP issued an RFP (S1070000015802) on January 20, 2026 with a response deadline of March 26, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Vendors must supply comprehensive pricing for identified pharmaceutical products with specific National Drug Codes (NDC), comply with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, and maintain insurance coverage including commercial general liability of $5,000,000 per occurrence. The contract term is two years for new responders with optional extensions at MMCAP's sole discretion, and all products must be available in the marketplace by May 15, 2026, with agreements effective July 1, 2026. Vendors must agree to a 3 percent administrative fee on all contract purchases and comply with performance penalties ranging from $200 to $1,500 per violation. No specific dollar amounts or award ranges are disclosed in the RFP.